Literature DB >> 15986737

DBS therapy for the vegetative state and minimally conscious state.

T Yamamoto1, K Kobayashi, M Kasai, H Oshima, C Fukaya, Y Katayama.   

Abstract

Twenty-one cases of a vegetative state (VS) and 5 cases of a minimally conscious state (MCS) caused by various kinds of brain damage were evaluated neurologically and electrophysiologically at 3 months after brain injury. These cases were treated by deep brain stimulation (DBS) therapy, and followed up for over 10 years. The mesencephalic reticular formation was selected as a target in 2 cases of VS, and the CM-pf complex was selected as a target in the other 19 cases of VS and 5 cases of MCS. Eight of the 21 patients emerged from the VS, and became able to obey verbal commands. However, they remained in a bedridden state except for 1 case. Four of the 5 MCS patients emerged from the bedridden state, and were able to enjoy their life in their own home. DBS therapy may be useful for allowing patients to emerge from the VS, if the candidates are selected according to appropriate neurophysiological criteria. Also, a special neurorehabilitation system may be necessary for emergence from the bedridden state in the treatment of VS patients. Further, DBS therapy is useful in MCS patients to achieve consistent discernible behavioral evidence of consciousness, and emergence from the bedridden state.

Entities:  

Mesh:

Year:  2005        PMID: 15986737     DOI: 10.1007/3-211-27577-0_17

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  9 in total

1.  Centromedian-parafascicular deep brain stimulation induces differential functional inhibition of the motor, associative, and limbic circuits in large animals.

Authors:  Joo Pyung Kim; Hoon-Ki Min; Emily J Knight; Penelope S Duffy; Osama A Abulseoud; Michael P Marsh; Katherine Kelsey; Charles D Blaha; Kevin E Bennet; Mark A Frye; Kendall H Lee
Journal:  Biol Psychiatry       Date:  2013-08-30       Impact factor: 13.382

2.  Bifocal extradural cortical stimulation-induced recovery of consciousness in the permanent post-traumatic vegetative state.

Authors:  Sergio Canavero; Barbara Massa-Micon; Franco Cauda; Elisa Montanaro
Journal:  J Neurol       Date:  2009-02-28       Impact factor: 4.849

Review 3.  Deep brain stimulation as a new therapeutic approach in therapy-resistant mental disorders: ethical aspects of investigational treatment.

Authors:  Jens Kuhn; Wolfgang Gaebel; Joachim Klosterkoetter; Christiane Woopen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-11       Impact factor: 5.270

4.  Resting-state networks link invasive and noninvasive brain stimulation across diverse psychiatric and neurological diseases.

Authors:  Michael D Fox; Randy L Buckner; Hesheng Liu; M Mallar Chakravarty; Andres M Lozano; Alvaro Pascual-Leone
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-29       Impact factor: 11.205

5.  The ethics of deep brain stimulation (DBS).

Authors:  Marcus Unterrainer; Fuat S Oduncu
Journal:  Med Health Care Philos       Date:  2015-11

6.  Combined Invasive Subcortical and Non-invasive Surface Neurophysiological Recordings for the Assessment of Cognitive and Emotional Functions in Humans.

Authors:  Carlos Trenado; Saskia Elben; David Petri; Jan Hirschmann; Stefan J Groiss; Jan Vesper; Alfons Schnitzler; Lars Wojtecki
Journal:  J Vis Exp       Date:  2016-05-19       Impact factor: 1.355

7.  Novel applications of deep brain stimulation.

Authors:  Tejas Sankar; Travis S Tierney; Clement Hamani
Journal:  Surg Neurol Int       Date:  2012-01-14

Review 8.  Music in disorders of consciousness.

Authors:  Jens D Rollnik; Eckart Altenmüller
Journal:  Front Neurosci       Date:  2014-07-03       Impact factor: 4.677

9.  Structural changes in brains of patients with disorders of consciousness treated with deep brain stimulation.

Authors:  Marina Raguž; Nina Predrijevac; Domagoj Dlaka; Darko Orešković; Ante Rotim; Dominik Romić; Fadi Almahariq; Petar Marčinković; Vedran Deletis; Ivica Kostović; Darko Chudy
Journal:  Sci Rep       Date:  2021-02-23       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.